Related Experiment Video
Updated: Jun 20, 2026
08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
[Molecular mechanisms of insomnia]
1Department of Molecular Behavioral Biology, Osaka Bioscience Institute.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 23, 2009
Summary
Prostaglandin D2 and adenosine are key to sleep. Inhibiting their pathways caused insomnia in mice, highlighting their critical role in regulating natural sleep cycles.
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Science
Context:
- Prostaglandin (PG) D2 and adenosine are known potent sleep-inducing substances.
- Their precise roles in physiological sleep regulation require further elucidation.
Purpose:
- To investigate the contribution of Prostaglandin D2 and adenosine to physiological sleep.
- To determine the impact of inhibiting PG D2 synthase or adenosine A2A receptors on sleep patterns.
Summary:
- Complete insomnia was induced in wild-type mice by inhibiting Prostaglandin D2 synthase (using SeCl4) or blocking adenosine A2A receptors (using caffeine).
- These insomnia effects were absent in gene-knockout mice lacking Prostaglandin D2 synthase, DP1 receptors, or adenosine A2A receptors.
- Administration of a DP1 antagonist (ONO-4127Na) to rats significantly reduced sleep, further supporting the role of this system.
Impact:
- The Prostaglandin D2/adenosine system is crucial for regulating normal physiological sleep.
- These findings provide a deeper understanding of the neurochemical basis of sleep.
- Potential implications for developing novel therapeutic strategies for sleep disorders.
Related Concept Videos
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...